Lotus Pharms Inc (LTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 18,694 | 12,917 | 20,100 | 18,505 | 19,105 |
| Cost of Goods | 13,800 | 6,760 | 9,650 | 7,920 | 9,100 |
| Gross Profit | 4,880 | 6,150 | 10,520 | 10,570 | 9,990 |
| Operating Expenses | 3,890 | 4,650 | 8,880 | 4,530 | 3,550 |
| Operating Income | 1,804 | 2,267 | 2,220 | 6,975 | 6,555 |
| Interest Expense | 60 | 60 | 60 | 60 | 60 |
| Other Income | 26 | 23 | -5,940 | -15 | -5 |
| Pre-tax Income | 1,770 | 2,230 | -3,780 | 6,900 | 6,490 |
| Income Tax | 0 | 0 | -240 | 200 | 160 |
| Net Income Continuous | 1,774 | 2,235 | -3,500 | 6,700 | 6,322 |
| Net Income | $1,774 | $2,235 | $-3,500 | $6,700 | $6,322 |
| EPS Basic Total Ops | 0.06 | 0.08 | -0.13 | 0.26 | 0.24 |
| EPS Basic Continuous Ops | 0.06 | 0.08 | -0.13 | 0.25 | 0.24 |
| EPS Diluted Total Ops | 0.06 | 0.08 | -0.13 | 0.24 | 0.24 |
| EPS Diluted Continuous Ops | 0.06 | 0.08 | -0.13 | 0.25 | 0.23 |
| EBITDA(a) | $2,214 | $2,667 | $3,130 | $7,425 | $7,005 |